High Signal Podcasts Evidence ledger
Method
Browse
← Back to evidence

Evidence receipt / belief

Published · transcript-backed

Nikhila Ravi: belief

7 Aug 2024 Latent Space Segment Anything 2: Demo-first Model Development

“I think we're not really exposed to that. Maybe you are at Roboflow because you get to see all the users of these tools.”

— Nikhila Ravi

Source trail

Everything needed to verify it.

Speaker
Nikhila Ravi
Attribution
Verified speaker
Claim type
belief
Recorded
7 Aug 2024
Publisher
Latent Space

Transcript context

…So, I mean, basically like in the first, the first year of a model being available, not only can you say, Hey, I'm just going to go use this model, those numbers that like 49 million images. is an estimate directly related to just the hosted side. So imagine all of the users that are self hosting or using SAM for robotics applications or out in the field or offline where it's not even, like, the time or the image counts are tabulated. And we're probably talking about, you know, just a fraction of the amount of value that's actually being produced for a number of downstream tasks. So to say that the impact has been You know, people use terms like game changing and these sorts of things. It has changed the industry. It's set a new standard. And with the release of SAM 2, I think we're about to see an acceleration of those capabilities for a lot of reasons. That's really great to hear. I think one of the, really SAM 1 was. How many fields actually rely on manual segmentation? I think we're not really exposed to that. Maybe you are at Roboflow because you get to see all the users of these tools. But for me, it was, you know, people working on understanding coral reef bleaching or farmers counting their cows and so many different applications that as a researcher. You never get exposed to, but you can have impact towards. So I think that was really awesome to hear. So as sort of audience surrogate, who knows less than the two of you, I'm going to ask a really dumb question maybe, but is everyone using stock, a segment, anything? Are they fine tuning for the medical domain? Like how on earth could it work for the medical field without fine tuning, right? Like, is that a thing?…

Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.

Search evidence